单侧 ELS Ⅲ型或双侧Ⅱ型切除术治疗 T1-T2 声门型喉癌 1 年后的嗓音结果。
Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year.
机构信息
Department of Otorhinolaryngology, Head & Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Department of Otorhinolaryngology, Head & Neck Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
出版信息
Head Neck. 2019 Jun;41(6):1638-1647. doi: 10.1002/hed.25582. Epub 2019 Jan 16.
BACKGROUND
Voice outcome was assessed in patients with extended T1 and limited T2 glottic carcinoma, treated with a unilateral type III or a bilateral type II resection according to the European Laryngological Society (ELS) classification.
METHODS
Objective evaluation (acoustic and aerodynamic parameters), perceptual evaluation (GRBAS), and patients' self-assessment (voice handicap index [VHI]) were performed before and 1 year after treatment. Results were evaluated according to ELS resection type and the involvement of the anterior commissure.
RESULTS
The majority of voice parameters in all resection subgroups showed an improvement of the mean score 1 year postoperatively. Grade of dysphonia varied between 1.15 and 1.66 postoperatively and VHI score varied from 23.3 to 24.5.
CONCLUSION
Voice outcome after ELS unilateral type III or a bilateral type II resection for extended T1 and limited T2 glottic carcinoma is good with mild to very moderate perceptive dysphonia and low self-reported voice impairment.
背景
根据欧洲喉科学会 (ELS) 分类，对 T1 期延长和 T2 期有限的声门型喉癌患者采用单侧 III 型或双侧 II 型切除术进行了嗓音预后评估。
方法
在治疗前和治疗后 1 年分别进行了客观评估（声学和空气动力学参数）、主观评估（GRBAS）和患者自我评估（嗓音障碍指数 [VHI]）。结果根据 ELS 切除术类型和前连合受累情况进行评估。
结果
所有切除术亚组的大多数嗓音参数在术后 1 年均显示出评分的改善。术后嗓音障碍程度评分为 1.15 至 1.66 级，VHI 评分为 23.3 至 24.5。
结论
对于 T1 期延长和 T2 期有限的声门型喉癌，采用 ELS 单侧 III 型或双侧 II 型切除术治疗后的嗓音预后良好，感知性发音障碍为轻度至非常中度，自我报告的嗓音障碍程度较低。
Zotero 插件